|
|
|
Insider
Information: |
Enright Patrick G |
Relationship: |
10% Owner |
City: |
Burlingame |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
16 |
|
Direct
Shares |
3,308,185 |
|
Indirect Shares
|
27,432,603 |
|
|
Direct
Value |
$10,796,077 |
|
|
Indirect Value
|
$115,153,143 |
|
|
Total
Shares |
30,740,788 |
|
|
Total
Value |
$125,949,221 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
6
|
1
|
Stock
price went up :
|
5
|
1
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
5.0
|
1.0
|
Percentage
Gain/Loss : |
95.0%
|
101.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Molecular Templates, Inc. |
MTEM |
Director |
2006-04-20 |
496 |
2007-03-01 |
0 |
Premium* |
|
Sequenom Inc |
SQNM |
Director |
2006-12-07 |
771 |
2006-12-07 |
3,333,333 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2017-03-16 |
272,281 |
2017-03-16 |
114,675 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
20,946 |
2022-08-08 |
2,000 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2013-07-01 |
0 |
2015-03-19 |
18,361 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
10% Owner |
2015-05-12 |
0 |
2015-05-12 |
65,270 |
Premium* |
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-10-10 |
0 |
Premium* |
|
Aptinyx Inc. |
APTX |
Director |
2020-01-10 |
95,000 |
2020-01-10 |
3,356,746 |
Premium* |
|
Tricida, Inc. |
TCDA |
|
2018-07-02 |
0 |
2018-07-02 |
3,019,734 |
Premium* |
|
Venus Concept Inc |
VERO |
10% Owner |
|
0 |
2019-11-07 |
3,666,119 |
Premium* |
|
89bio, Inc. |
ETNB |
10% Owner |
2019-11-11 |
0 |
2020-11-16 |
891 |
Premium* |
|
Sierra Oncology Inc |
SRRA |
10% Owner |
2020-01-29 |
0 |
2022-01-25 |
1,964,771 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2022-04-19 |
4,174,379 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2021-04-14 |
2,918,691 |
2021-04-14 |
5,012 |
Premium* |
|
Vera Therapeutics, Inc. |
VERA |
Director, 10% Owner |
2021-05-18 |
0 |
2023-02-06 |
5,144,212 |
Premium* |
|
Lexeo Therapeutics, Inc. |
LXEO |
10% Owner |
2023-11-07 |
0 |
2023-11-07 |
2,567,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2013-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2013-08-13 |
4 |
S |
$81.86 |
$87,590 |
D/D |
(1,070) |
3,430 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-02-28 |
4 |
OE |
$4.00 |
$3,791,468 |
I/I |
947,867 |
18,624 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-02-28 |
4 |
S |
$150.50 |
$83,507,487 |
I/I |
(547,867) |
7,858 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-03-03 |
4 |
S |
$147.87 |
$1,772,775 |
I/I |
(11,761) |
0 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-03-05 |
4 |
S |
$4.01 |
$286,568 |
I/I |
(71,467) |
186,325 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-03-06 |
4 |
S |
$4.00 |
$672,530 |
I/I |
(168,103) |
183,022 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-03-07 |
4 |
S |
$4.00 |
$41,720 |
I/I |
(10,430) |
182,817 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-04-01 |
4 |
S |
$4.28 |
$1,070,575 |
I/I |
(250,000) |
177,905 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-05-01 |
4 |
S |
$4.12 |
$674,591 |
I/I |
(163,557) |
174,691 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2014-05-02 |
4 |
S |
$4.07 |
$351,979 |
I/I |
(86,443) |
172,992 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650 |
5,080 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-08-12 |
4 |
S |
$133.15 |
$144,734 |
D/D |
(1,087) |
3,993 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-09-02 |
4 |
S |
$162.71 |
$1,629,387 |
I/I |
(10,000) |
7,661 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-10-06 |
4 |
S |
$159.47 |
$1,605,633 |
I/I |
(10,000) |
7,465 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2014-10-07 |
4 |
S |
$30.04 |
$358,289 |
I/I |
(11,927) |
37,776 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2014-10-09 |
4 |
S |
$30.00 |
$28,290 |
I/I |
(943) |
37,757 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-11-10 |
4 |
S |
$170.90 |
$1,710,858 |
I/I |
(10,000) |
7,268 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2014-11-17 |
4 |
S |
$32.01 |
$15,804,823 |
I/I |
(482,026) |
28,286 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2014-11-18 |
4 |
S |
$31.56 |
$161,346 |
I/I |
(5,104) |
28,186 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-12-01 |
4 |
S |
$170.96 |
$1,727,424 |
I/I |
(10,000) |
7,072 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-12-12 |
4 |
S |
$170.32 |
$400,603 |
D/D |
(2,343) |
1,650 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-01-05 |
4 |
S |
$159.68 |
$1,602,483 |
I/I |
(10,000) |
6,875 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-02-10 |
4 |
S |
$166.45 |
$1,668,518 |
I/I |
(10,000) |
6,679 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-03-02 |
4 |
S |
$172.60 |
$1,760,031 |
I/I |
(10,000) |
6,482 |
0 |
- |
|
169 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|